Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011881 (
diabetic nephropathy
)
10,836
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Renalase
, a recently discovered secreted flavoprotein, exerts anti-apoptotic and anti-inflammatory effects against renal injury in acute and chronic animal models. However, whether
Renalase
elicits similar effects in the development of
diabetic nephropathy
(DN) remains unclear. The studies presented here tested the hypothesis that
Renalase
may play a key role in the development of DN and may have therapeutic potential for DN.
Renalase
expression was measured in human kidney biopsies with DN and in kidneys of db/db mice. The role of
Renalase
in the development of DN was examined using a genetically engineered mouse model:
Renalase
knockout mice with db/db background. The renoprotective effects of
Renalase
in DN was evaluated in db/db mice with
Renalase
overexpression. In addition, the effects of
Renalase
on high glucose-induced mesangial cells were investigated.
Renalase
was down-regulated in human diabetic kidneys and in kidneys of db/db mice compared with healthy controls or db/m mice.
Renalase
homozygous knockout increased arterial blood pressure significantly in db/db mice while heterozygous knockout did not.
Renalase
heterozygous knockout resulted in elevated albuminuria and increased renal mesangial expansion in db/db mice. Mesangial hypertrophy, renal inflammation, and pathological injury in diabetic
Renalase
heterozygous knockout mice were significantly exacerbated compared with wild-type littermates. Moreover,
Renalase
overexpression significantly ameliorated renal injury in db/db mice. Mechanistically,
Renalase
attenuated high glucose-induced profibrotic gene expression and p21 expression through inhibiting extracellular regulated protein kinases (ERK1/2). The present study suggested that
Renalase
protected against the progression of DN and might be a novel therapeutic target for the treatment of DN.
...
PMID:A protective role of renalase in diabetic nephropathy. 3189 83